NDC11 70594007201
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 70594-0072-01 | 70594-0072 |
| 70594-0072-1 | 70594-0072 |
| 70594-072-01 | 70594-072 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Neostigmine Methylsulfate | NEOSTIGMINE METHYLSULFATE | Xellia Pharmaceuticals USA LLC | 398d8193-e1e8-42b5-a95a-86cde967c7d0 | 2021-10-25 | Warnings, Adverse reactions | 70594-072-01 70594-072 70594007201 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.